Descriptive Assessment of Coagulopathy Among COVID-19 Patients in the Inpatient Setting: A Sentinel Feasibility Study

Project Title Descriptive Assessment of Coagulopathy Among COVID-19 Patients in the Inpatient Setting: A Sentinel Feasibility Study
Date Posted
Wednesday, June 17, 2020
Status
In progress
Description

The purpose of this project is to describe the natural history of coagulopathy among COVID-19 patients in the inpatient setting. Activities will include development of a study synopsis for a descriptive study of coagulopathy among hospitalized COVID-19 patients, as well as assessment of feasibility of study implementation within inpatient settings. The Sentinel Operations Center (SOC) is partnering with leading infectious disease and hematology specialists on this activity.

Workgroup Leader(s)

Jeffrey Brown, PhD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

Vincent Lo Re, MD, MSCE; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania

Workgroup Members

Danijela Stojanovic, PharmD, PhD; Brian Kit, MD, MPH; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD

Meighan Rogers Driscoll, MPH; Maria Kempner, MPH; Jenice Ko; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

Health Outcome
arterial thromboembolic events
venous thromboembolic events
Population / Cohort
COVID-19 positive population
Time Period
June 2020 - December 2020
Related Links
Scroll to Top